Join Growin Stock Community!
Back to RXRX.US Analysis
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

operating-expenses-chart

RXRX Operating Expenses

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

As of Q4'25, RXRX reported R&D Expenses of USD 95.94M and SG&A Expenses of USD 33.66M, marking a notable decrease from the previous quarters. This latest data point reflects a significant reduction in both operating expense categories compared to the peaks observed earlier in 2025. Over the period from Q1'23 to Q4'25, RXRX's operating expenses exhibited a general upward trend, with R&D Expenses rising sharply to a high of USD 129.63M in Q1'25 before declining in the subsequent quarters. SG&A Expenses followed a similar pattern, peaking at USD 77.19M in Q4'24 and then trending downward. The data suggests a period of accelerated investment through 2024 and early 2025, followed by a strategic pullback in spending towards the end of the observed timeframe.